Maternal betaine supplementation ameliorates fatty liver disease in offspring mice by inhibiting hepatic NLRP3 inflammasome activation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: Previous research has shown maternal betaine supplementation alleviates fetal-derived hepatic steatosis. Therefore, this study examined the anti-inflammatory effect of maternal betaine intake in offspring mice and its mechanism. MATERIALS/METHODS: Female C57BL/6J mice and their offspring were randomly divided into 3 groups according to the treatment received during gestation and lactation: control diet (CD), fatty liver disease (FLD), and fatty liver disease + 1% betaine (FLD-BET). The FLD group was given a high-fat diet and streptozotocin (HFD + STZ), and the FLD-BET group was treated with HFD + STZ + 1% betaine. After weaning, the offspring mice were given a normal diet for 5 weeks and then dissected to measure the relevant indexes. RESULTS: Compared to the CD group, the offspring mice in the FLD group revealed obvious hepatic steatosis and increased serum levels of alanine aminotransferase, interleukin (IL)-6, and tumor necrosis factor (TNF)-α; maternal betaine supplementation reversed these changes. The hepatic mRNA expression levels of IL-6, IL-18, and Caspase-1 were significantly higher in the FLD group than in the CD group. Maternal betaine supplementation reduced the expression of IL-1β, IL-6, IL-18, and apoptosis-associated speck-like protein containing C-terminal caspase recruitment domain (ASC). Maternal betaine supplementation also reversed the increasing protein expressions of nitric oxide dioxygenase-like receptor family pyrin domain containing 3 (NLRP3), ASC, Caspase-1, IL-1β, and IL-18 in offspring mice exposed to HFD + STZ. Maternal betaine supplementation decreased the homocysteine (Hcy) and s-adenosine homocysteine (SAH) levels significantly in the livers. Furthermore, the hepatic Hcy concentrations showed significant inverse relationships with the mRNA expression of TNF-α, NLRP3, ASC, and IL-18. The hepatic SAH concentration was inversely associated with the IL-1β mRNA expression. CONCLUSIONS: The lipotropic and anti-inflammatory effect of maternal betaine supplementation may be associated with the inhibition of NLRP3 inflammasome in the livers of the offspring mice.
Abstract
BACKGROUND/OBJECTIVES: Previous research has shown maternal betaine supplementation alleviates fetal-derived hepatic steatosis. Therefore, this study examined the anti-inflammatory effect of maternal betaine intake in offspring mice and its mechanism. MATERIALS/METHODS: Female C57BL/6J mice and their offspring were randomly divided into 3 groups according to the treatment received during gestation and lactation: control diet (CD), fatty liver disease (FLD), and fatty liver disease + 1% betaine (FLD-BET). The FLD group was given a high-fat diet and streptozotocin (HFD + STZ), and the FLD-BET group was treated with HFD + STZ + 1% betaine. After weaning, the offspring mice were given a normal diet for 5 weeks and then dissected to measure the relevant indexes. RESULTS: Compared to the CD group, the offspring mice in the FLD group revealed obvious hepatic steatosis and increased serum levels of alanine aminotransferase, interleukin (IL)-6, and tumor necrosis factor (TNF)-α; maternal betaine supplementation reversed these changes. The hepatic mRNA expression levels of IL-6, IL-18, and Caspase-1 were significantly higher in the FLD group than in the CD group. Maternal betaine supplementation reduced the expression of IL-1β, IL-6, IL-18, and apoptosis-associated speck-like protein containing C-terminal caspase recruitment domain (ASC). Maternal betaine supplementation also reversed the increasing protein expressions of nitric oxide dioxygenase-like receptor family pyrin domain containing 3 (NLRP3), ASC, Caspase-1, IL-1β, and IL-18 in offspring mice exposed to HFD + STZ. Maternal betaine supplementation decreased the homocysteine (Hcy) and s-adenosine homocysteine (SAH) levels significantly in the livers. Furthermore, the hepatic Hcy concentrations showed significant inverse relationships with the mRNA expression of TNF-α, NLRP3, ASC, and IL-18. The hepatic SAH concentration was inversely associated with the IL-1β mRNA expression. CONCLUSIONS: The lipotropic and anti-inflammatory effect of maternal betaine supplementation may be associated with the inhibition of NLRP3 inflammasome in the livers of the offspring mice.
참고문헌 (33)
- Saiman Y, "Fatty liver disease : diagnosis and stratification", Annu Rev Med, 73, pp.529~544 (2022)
- Campisano S, "Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases", Nutr Res Rev, 32, pp.128~145 (2019)
- Li M, "Developmental programming of nonalcoholic fatty liver disease : the effect of early life nutrition on susceptibility and disease severity in later life", BioMed Res Int, 2015, pp.437107~ (2015)
- Hagström H, "Maternal obesity increases the risk and severity of NAFLD in offspring", J Hepatol, 75, pp.1042~1048 (2021)
- Brumbaugh DE, "Intrahepatic fat is increased in the neonatal offspring of obese women with gestational diabetes", J Pediatr, 162, pp.930~936 (2013)[DOI]
- Henao-Mejia J, "Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity", Nature, 482, pp.179~185 (2012)
- Wree A, "NLRP3inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice", Hepatology, 59, pp.898~910 (2014)
- Dwivedi DK, "NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat : studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway", Naunyn Schmiedebergs Arch Pharmacol, 393, pp.705~716 (2020)
- Zhang Y, "Demethylenetetrahydroberberine alleviates nonalcoholic fatty liver disease by inhibiting the NLRP3 inflammasome and oxidative stress in mice", Life Sci, 281, pp.119778~ (2021)
- Wang LJ, "Betaine attenuates hepatic steatosis by reducing methylation of the MTTP promoter and elevating genomic methylation in mice fed a high-fat diet", J Nutr Biochem, 25, pp.329~336 (2014)
- Wang L, "Betaine supplement alleviates hepatic triglyceride accumulation of apolipoprotein E deficient mice via reducing methylation of peroxisomal proliferatoractivated receptor alpha promoter", Lipids Health Dis, 12, pp.34~ (2013)
- Sun L, "Maternal betaine supplementation mitigates maternal high fat diet-induced NAFLD in offspring mice through gut microbiota", Nutrients, 15, pp.284~ (2023)
- Zhao G, "Betaine in inflammation : mechanistic aspects and applications", Front Immunol, 9, pp.1070~ (2018)
- Ge CX, "Betaine prevented fructose-induced NAFLD by regulating LXRα", PPARα pathway and alleviating ER stress in rats, 2016, pp.770, 154~164
- Szkudelski T, "The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas", Physiol Res, 50, pp.537~546 (2001)
- Dong X, "Intrauterine hyperglycemia induces liver inflammation in mouse male offspring", Int Immunopharmacol, 99, pp.107974~ (2021)
- Lo L, "Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of nonalcoholic steatohepatitis", J Hepatol, 55, pp.435~444 (2011)
- Santhekadur PK, "Preclinical models of non-alcoholic fatty liver disease", J Hepatol, 68, pp.230~237 (2018)
- Kleiner DE, "Design and validation of a histological scoring system for nonalcoholic fatty liver disease", Hepatology, 41, pp.1313~1321 (2005)
- Hu Y, "Corticosterone-induced lipogenesis activation and lipophagy inhibition in chicken liver are alleviated by maternal betaine supplementation", J Nutr, 148, pp.316~325 (2018)
- Joselit Y, "Maternal betaine supplementation affects fetal growth and lipid metabolism of high-fat fed mice in a temporal-specific manner", Nutr Diabetes, 8, pp.41~ (2018)
- Zhao N, "Maternal betaine supplementation attenuates glucocorticoidinduced hepatic lipid accumulation through epigenetic modification in adult offspring rats", J Nutr Biochem, 54, pp.105~112 (2018)
- Soderborg TK, "The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD", Nat Commun, 9, pp.4462~ (2018)
- Knorr J, "The NLRP3 inflammasome in alcoholic and nonalcoholic steatohepatitis", Semin Liver Dis, 40, pp.298~306 (2020)
- 서윤용, "Tumor Necrosis Factor-α as a Predictor for the Development of Nonalcoholic Fatty Liver Disease:A 4-Year Follow-Up Study", Endocrinology and Metabolism, 28(1), pp.41~45 (2013), 대한내분비학회
- Wu Q, "Translation and mRNA stability control", Annu Rev Biochem, 92, pp.227~245 (2023)
- Vogel C, "Insights into the regulation of protein abundance from proteomic and transcriptomic analyses", Nat Rev Genet, 13, pp.227~232 (2012)
- Kim DH, "Effect of betaine on hepatic insulin resistance through FOXO1-induced NLRP3 inflammasome", J Nutr Biochem, 45, pp.104~114 (2017)
- Wei M, "NLRP3 activation was regulated by DNA methylation modification during mycobacterium tuberculosis infection", BioMed Res Int, 2016, pp.4323281~ (2016)
- Wang R, "Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice", Lab Invest, 97, pp.922~934 (2017)
- Conley SM, "Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia", Free Radic Biol Med, 106, pp.236~244 (2017)
- Jacobsen DW, "Hyperhomocysteinemia and oxidative stress : time for a reality check?", Arterioscler Thromb Vasc Biol, 20, pp.1182~1184 (2000)
- Schroder K, "The inflammasomes", Cell, 140, pp.821~832 (2010)